Ginkgo Bioworks Reports Q1 2026 Earnings
Ginkgo Bioworks (DNA) reported a significant revenue decline in the first quarter of 2026, with $19 million compared to $37.5 million in the same period last year due largely to noncash revenue from an agreement termination. The company also posted a net loss and negative adjusted EBITDA but noted cost reductions across R&D and G&A expenses.
Tickers: $DNA
Topics: adjusted EBITDA cash burn G&A expense net loss R&D expense revenue